Queen's Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Queen's Medical Center sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).
Queen's Medical Center: 17 sponsored US clinical trials, 5 recruiting.
Queen's Medical Center sponsors 17 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 8 completed. 3 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pain With Gynecology Procedure, with 1 trials.
Top-decile sponsor footprint
Queen's Medical Center ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
8 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
17 total, page 1 of 1
Vapocoolant Spray to Reduce Pain With Nexplanon Insertion
NCT06933381
Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision
NCT06951438
Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii
NCT06532370
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
NCT05753813
Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma
NCT04965454
Feasibility and Acceptability of Point of Care Rapid Syphilis Testing Among Patients Seeking Family Planning Services in Hawai'i
NCT07358949
Why Wait? Initiating Contingency Management in Traumatically Injured Patients During Hospitalization
NCT06931197
TENS Unit To Decrease Pain After Laminaria Insertion
NCT06529003
Applying Num Vapocoolant Spray to Cervix Before Paracervical Block to Decrease Pain During Gynecology Procedures
NCT06227052
Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS
NCT04412772
A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients
NCT04345692
PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection
NCT01395030
Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer
NCT00928174
Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer
NCT00928252
Comedy in Chemotherapy (COMIC) Study
NCT01037933
Kukui Ahi Navigator Cancer Screening and Treatment Demonstration Project
NCT00379782
Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography
NCT01310192
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 3 |
| Phase 3 | 2 |
| Phase 4 | 1 |
Therapeutic Areas
What is open in the Queen's Medical Center pipeline
5 recruiting of 17 indexed (29% open); 8 completed (47%).
Phase mix: 3 late (III/IV) vs 7 early (I/II) (early-phase heavy).
Top condition: Pain With Gynecology Procedure (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Queen's Medical Center: open-pipeline peers nationwide
Peers matched on 17 registered trials and 29% open enrollment, not the therapeutic-area sidebar.
Queen's Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 17 trials (± recruiting share)
- Achieve Life Sciences · 17 trials · 0% recruiting
- BioDelivery Sciences International · 17 trials · 6% recruiting
- Chugai Pharmaceutical · 17 trials · 24% recruiting
- ConvaTec · 17 trials · 18% recruiting
Sponsors near 29% open enrollment (± trial volume)
- Children's Hospital Los Angeles · 29% recruiting · 119 trials
- Natural Immune Systems · 29% recruiting · 17 trials
- Ono Pharmaceutical Co. · 29% recruiting · 17 trials
- Inova Health Care Services · 29% recruiting · 75 trials
Related
What to do with this Queen's Medical Center page
17 registered trials is a research-attention snapshot, not an endorsement of Queen's Medical Center or any single study.
- 5 of Queen's Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Pain With Gynecology Procedure is the condition Queen's Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pain With Gynecology Procedure trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Queen's Medical Center pipeline card: 17 registered trials from official public datasets.Report a data error.